From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

SHOULD SILENT ISCHEMIA BE SUPPRESSED?

Should electrocardiographic ischemia be treated even if it causes no symptoms? As a first step toward answering this question, the Asymptomatic Cardiac Ischemia Pilot (ACIP) study evaluated 618 patients who had coronary artery disease suitable for revascularization, ischemia on stress testing, and asymptomatic ischemia on ambulatory ECG monitoring.

The patients were randomized to one of three treatment strategies: medical therapy aimed at relieving angina, therapy to relieve both angina and ischemia on ambulatory monitoring, or revascularization by angioplasty or bypass surgery.

At 12 weeks, 39 percent, 41 percent, and 55 percent of these groups, respectively, were free of ischemia on ambulatory monitoring. Patients whose treatment was guided by ambulatory monitoring received higher average doses of beta- and calcium-blockers than those whose therapy was guided by symptoms only. Complication rates were similar in the three groups, but this pilot study lacked sufficient power to detect differences in clinical outcome.

Comment: This study shows that treatment guided by symptoms alone abolished ischemia as effectively as therapy to eliminate silent ECG-detected ischemia, even though the more aggressive approach used more medications. It will take a long-term, large-scale randomized trial to determine whether treating silent ischemia can prevent coronary events and deaths.

— TH Lee

Published in Journal Watch General Medicine July 15, 1994

Citation(s):

Knatterud GL et al. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. J Am Coll Cardiol 1994 Jul 24 11-20.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 1994. Massachusetts Medical Society. All rights reserved.